Wells Fargo’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,048
| Closed | -$163K | – | 7852 |
|
|
2022
Q4 | $163K | Sell |
6,048
-14,637
| -71% | -$385K | ﹤0.01% | 4285 |
|
|
2022
Q3 | $371K | Sell |
20,685
-2,263
| -10% | -$36.1K | ﹤0.01% | 3879 |
|
|
2022
Q2 | $285K | Sell |
22,948
-2,204
| -9% | -$24.3K | ﹤0.01% | 4095 |
|
|
2022
Q1 | $335K | Sell |
25,152
-1,619
| -6% | -$21.7K | ﹤0.01% | 4685 |
|
|
2021
Q4 | $417K | Sell |
26,771
-2,395
| -8% | -$45.7K | ﹤0.01% | 4805 |
|
|
2021
Q3 | $654K | Sell |
29,166
-1,318
| -4% | -$28.9K | ﹤0.01% | 4504 |
|
|
2021
Q2 | $694K | Sell |
30,484
-567
| -2% | -$11.9K | ﹤0.01% | 4444 |
|
|
2021
Q1 | $639K | Buy |
31,051
+7,440
| +32% | +$169K | ﹤0.01% | 4557 |
|
|
2020
Q4 | $652K | Buy |
23,611
+9,231
| +64% | +$180K | ﹤0.01% | 4336 |
|
|
2020
Q3 | $202K | Sell |
14,380
-10,507
| -42% | -$195K | ﹤0.01% | 4957 |
|
|
2020
Q2 | $513K | Buy |
24,887
+16,357
| +192% | +$222K | ﹤0.01% | 4307 |
|
|
2020
Q1 | $64K | Buy |
8,530
+2,200
| +35% | +$24.7K | ﹤0.01% | 5260 |
|
|
2019
Q4 | $98K | Buy |
6,330
+6,030
| +2,010% | +$60.8K | ﹤0.01% | 5304 |
|
|
2019
Q3 | $2K | Sell |
300
-13,040
| -98% | -$96.7K | ﹤0.01% | 6226 |
|
|
2019
Q2 | $121K | Sell |
13,340
-8,256
| -38% | -$123K | ﹤0.01% | 5226 |
|
|
2019
Q1 | $515K | Sell |
21,596
-844
| -4% | -$17.3K | ﹤0.01% | 4311 |
|
|
2018
Q4 | $368K | Buy |
+22,440
| New | +$442K | ﹤0.01% | 4530 |
|
|
2017
Q2 | – | Sell |
-16,527
| Closed | -$194K | – | 6525 |
|
|
2017
Q1 | $194K | Buy |
16,527
+12,700
| +332% | +$146K | ﹤0.01% | 4828 |
|
|
2016
Q4 | $48K | Buy |
+3,827
| New | +$44.3K | ﹤0.01% | 5384 |
|
Other funds holding MYOV
Wells Fargo's MYOV Position: Q1 2023 in Review
Wells Fargo sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 6,048 shares — an estimated $163K sold.
Wells Fargo first reported a position in MYOV in Q4 2016 and held it in 19 quarters. The position peaked at $694K in Q2 2021. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- Wells Fargo reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- Wells Fargo sold 6,048 Myovant Sciences Ltd. shares in Q1 2023, an estimated $163K.
- Wells Fargo first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 19 quarters.
- Wells Fargo's Myovant Sciences Ltd. position peaked at $694K in Q2 2021.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.